Related Experiment Video
Updated: Apr 15, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
1.0K
Psoriasis and dyslipidemia
Eldina Malkic Salihbegovic1, Nermina Hadzigrahic2, Edin Suljagic3
1Health Center Zivinice, Bosnia and Herzegovina.
Materia Socio-Medica
|April 15, 2015
Summary
Psoriasis patients frequently experience dyslipidemia, a condition affecting lipid levels. This study found a significant link between psoriasis severity and the presence of dyslipidemia.
Area of Science:
- Dermatology
- Cardiovascular Health
- Metabolic Disorders
Background:
- Psoriasis is a chronic inflammatory skin condition.
- Psoriasis is associated with various comorbidities.
- Dyslipidemia is a common comorbidity in psoriasis patients.
Purpose of the Study:
- To investigate the prevalence of dyslipidemia in patients with psoriasis.
- To explore the relationship between psoriasis severity and dyslipidemia.
Main Methods:
- A study was conducted on 70 adult patients diagnosed with psoriasis.
- Data collected included patient demographics, psoriasis duration, and lipid profiles.
- Psoriasis severity was assessed using the Psoriasis Area and Severity Index (PASI) score.
Main Results:
- A high frequency of dyslipidemia (62.85%) was observed in the psoriasis cohort.
- Hypertriglyceridemia and low HDL cholesterol were the most common lipid abnormalities.
- A statistically significant positive correlation was found between PASI scores and the presence of dyslipidemia (r=0.41; p=0.0001).
Conclusions:
- Psoriasis is significantly associated with dyslipidemia.
- Increased psoriasis severity correlates with a higher likelihood of dyslipidemia.
- These findings highlight the importance of screening for dyslipidemia in psoriasis patients.
Related Concept Videos
01:26Atherosclerosis III: Management
603
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
603
01:38Inflammation
65.3K
Overview
65.3K
01:29Cholesterol: Significance and Regulation
2.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
2.0K
01:24Overview of Lipid Metabolism
7.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
7.1K
01:30Atherosclerosis I: Introduction
2.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.9K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.9K